TARRIFF SCOTT (CEO) sold 2.5% of their position (15K shares) of EAGLE PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $299.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/18/2023ACC: 0001209191-23-030725
DirectorOfficer· CEO
Since Jun 2018
-15K
Net shares
Net seller
$299.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
15K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−15K
Price / share
$19.98
Trade value
$299.70K
% of position
2.5%
5/16/2023
602.31K→587.31K
Total
Net shares
−15K
Net value
-$299.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/16/2023 | S · Sale | −15K | $19.98 | $299.70K | 2.5% | 602.31K | 587.31K |
| Total | −15K | -$299.70K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned992.62K
Total
992.62K indirect992.62K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 992.62K | Indirect |
| Total | 992.62K | 992.62K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported